aluates Reports

$ 0.0

Automative

Global Insomnia Pharmacological Treatment Market Research Report 2025

Published Date: January 2025

Report Code: QYRE-Auto-38V6035

Global Insomnia Pharmacological Treatment Market Insights Forecast to 2028

BUY CHAPTERS

Global Insomnia Pharmacological Treatment Market Research Report 2025

Code: QYRE-Auto-38V6035

Report

January 2025

Pages:71

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Eisai, Co. Ltd. (Japan)

Merck & Co., Inc. (US)

Meda Consumer Healthcare Inc(US)

Pfizer Inc. (US)

Sanofi (France)

Takeda Pharmaceutical Company Ltd. (Japan)

Pernix Therapeutics(US)

Purdue Pharma L.P. (US)

Insomnia Pharmacological Treatment Market Size

The global market for Insomnia Pharmacological Treatment was valued at US$ 3034 million in the year 2024 and is projected to reach a revised size of US$ 3824 million by 2031, growing at a CAGR of 3.4% during the forecast period.

Insomnia Pharmacological Treatment Market

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Insomnia Pharmacological Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Insomnia Pharmacological Treatment.

The Insomnia Pharmacological Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Insomnia Pharmacological Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Insomnia Pharmacological Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Insomnia Pharmacological Treatment Market Report

Report Metric	Details
Report Name	Insomnia Pharmacological Treatment Market
Accounted market size in year	US$ 3034 million
Forecasted market size in 2031	US$ 3824 million
CAGR	3.4%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Prescription Sleep Aids Over-the-Counter Sleep Aids
Segment by Application	Homecare Clinic Hospital
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Eisai, Co. Ltd. (Japan), Merck & Co., Inc (US), Meda Consumer Healthcare Inc (US), Pfizer, Inc (US), Sanofi (France), Takeda Pharmaceutical Company Ltd. (Japan), Pernix Therapeutics (US), Purdue Pharma L.P (US)
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Insomnia Pharmacological Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Insomnia Pharmacological Treatment Market growing?

Ans: The Insomnia Pharmacological Treatment Market witnessing a CAGR of 3.4% during the forecast period 2025-2031.

What is the Insomnia Pharmacological Treatment Market size in 2031?

Ans: The Insomnia Pharmacological Treatment Market size in 2031 will be US$ 3824 million.

Who are the main players in the Insomnia Pharmacological Treatment Market report?

Ans: The main players in the Insomnia Pharmacological Treatment Market are Eisai, Co. Ltd. (Japan), Merck & Co., Inc (US), Meda Consumer Healthcare Inc (US), Pfizer, Inc (US), Sanofi (France), Takeda Pharmaceutical Company Ltd. (Japan), Pernix Therapeutics (US), Purdue Pharma L.P (US)

What are the Application segmentation covered in the Insomnia Pharmacological Treatment Market report?

Ans: The Applications covered in the Insomnia Pharmacological Treatment Market report are Homecare, Clinic, Hospital

What are the Type segmentation covered in the Insomnia Pharmacological Treatment Market report?

Ans: The Types covered in the Insomnia Pharmacological Treatment Market report are Prescription Sleep Aids, Over-the-Counter Sleep Aids

Recommended Reports

Sleep & Mental Disorders

Insomnia & Sleep Therapy

Neurology & Chronic Drugs

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Insomnia Pharmacological Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Prescription Sleep Aids

1.2.3 Over-the-Counter Sleep Aids

1.3 Market by Application

1.3.1 Global Insomnia Pharmacological Treatment Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Homecare

1.3.3 Clinic

1.3.4 Hospital

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Insomnia Pharmacological Treatment Market Perspective (2020-2031)

2.2 Global Insomnia Pharmacological Treatment Growth Trends by Region

2.2.1 Global Insomnia Pharmacological Treatment Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Insomnia Pharmacological Treatment Historic Market Size by Region (2020-2025)

2.2.3 Insomnia Pharmacological Treatment Forecasted Market Size by Region (2026-2031)

2.3 Insomnia Pharmacological Treatment Market Dynamics

2.3.1 Insomnia Pharmacological Treatment Industry Trends

2.3.2 Insomnia Pharmacological Treatment Market Drivers

2.3.3 Insomnia Pharmacological Treatment Market Challenges

2.3.4 Insomnia Pharmacological Treatment Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Insomnia Pharmacological Treatment Players by Revenue

3.1.1 Global Top Insomnia Pharmacological Treatment Players by Revenue (2020-2025)

3.1.2 Global Insomnia Pharmacological Treatment Revenue Market Share by Players (2020-2025)

3.2 Global Insomnia Pharmacological Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Insomnia Pharmacological Treatment Revenue

3.4 Global Insomnia Pharmacological Treatment Market Concentration Ratio

3.4.1 Global Insomnia Pharmacological Treatment Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Insomnia Pharmacological Treatment Revenue in 2024

3.5 Global Key Players of Insomnia Pharmacological Treatment Head office and Area Served

3.6 Global Key Players of Insomnia Pharmacological Treatment, Product and Application

3.7 Global Key Players of Insomnia Pharmacological Treatment, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Insomnia Pharmacological Treatment Breakdown Data by Type

4.1 Global Insomnia Pharmacological Treatment Historic Market Size by Type (2020-2025)

4.2 Global Insomnia Pharmacological Treatment Forecasted Market Size by Type (2026-2031)

5 Insomnia Pharmacological Treatment Breakdown Data by Application

5.1 Global Insomnia Pharmacological Treatment Historic Market Size by Application (2020-2025)

5.2 Global Insomnia Pharmacological Treatment Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Insomnia Pharmacological Treatment Market Size (2020-2031)

6.2 North America Insomnia Pharmacological Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Insomnia Pharmacological Treatment Market Size by Country (2020-2025)

6.4 North America Insomnia Pharmacological Treatment Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Insomnia Pharmacological Treatment Market Size (2020-2031)

7.2 Europe Insomnia Pharmacological Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Insomnia Pharmacological Treatment Market Size by Country (2020-2025)

7.4 Europe Insomnia Pharmacological Treatment Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Insomnia Pharmacological Treatment Market Size (2020-2031)

8.2 Asia-Pacific Insomnia Pharmacological Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Insomnia Pharmacological Treatment Market Size by Region (2020-2025)

8.4 Asia-Pacific Insomnia Pharmacological Treatment Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Insomnia Pharmacological Treatment Market Size (2020-2031)

9.2 Latin America Insomnia Pharmacological Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Insomnia Pharmacological Treatment Market Size by Country (2020-2025)

9.4 Latin America Insomnia Pharmacological Treatment Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Insomnia Pharmacological Treatment Market Size (2020-2031)

10.2 Middle East & Africa Insomnia Pharmacological Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Insomnia Pharmacological Treatment Market Size by Country (2020-2025)

10.4 Middle East & Africa Insomnia Pharmacological Treatment Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Eisai, Co. Ltd. (Japan)

11.1.1 Eisai, Co. Ltd. (Japan) Company Details

11.1.2 Eisai, Co. Ltd. (Japan) Business Overview

11.1.3 Eisai, Co. Ltd. (Japan) Insomnia Pharmacological Treatment Introduction

11.1.4 Eisai, Co. Ltd. (Japan) Revenue in Insomnia Pharmacological Treatment Business (2020-2025)

11.1.5 Eisai, Co. Ltd. (Japan) Recent Development

11.2 Merck & Co., Inc (US)

11.2.1 Merck & Co., Inc (US) Company Details

11.2.2 Merck & Co., Inc (US) Business Overview

11.2.3 Merck & Co., Inc (US) Insomnia Pharmacological Treatment Introduction

11.2.4 Merck & Co., Inc (US) Revenue in Insomnia Pharmacological Treatment Business (2020-2025)

11.2.5 Merck & Co., Inc (US) Recent Development

11.3 Meda Consumer Healthcare Inc (US)

11.3.1 Meda Consumer Healthcare Inc (US) Company Details

11.3.2 Meda Consumer Healthcare Inc (US) Business Overview

11.3.3 Meda Consumer Healthcare Inc (US) Insomnia Pharmacological Treatment Introduction

11.3.4 Meda Consumer Healthcare Inc (US) Revenue in Insomnia Pharmacological Treatment Business (2020-2025)

11.3.5 Meda Consumer Healthcare Inc (US) Recent Development

11.4 Pfizer, Inc (US)

11.4.1 Pfizer, Inc (US) Company Details

11.4.2 Pfizer, Inc (US) Business Overview

11.4.3 Pfizer, Inc (US) Insomnia Pharmacological Treatment Introduction

11.4.4 Pfizer, Inc (US) Revenue in Insomnia Pharmacological Treatment Business (2020-2025)

11.4.5 Pfizer, Inc (US) Recent Development

11.5 Sanofi (France)

11.5.1 Sanofi (France) Company Details

11.5.2 Sanofi (France) Business Overview

11.5.3 Sanofi (France) Insomnia Pharmacological Treatment Introduction

11.5.4 Sanofi (France) Revenue in Insomnia Pharmacological Treatment Business (2020-2025)

11.5.5 Sanofi (France) Recent Development

11.6 Takeda Pharmaceutical Company Ltd. (Japan)

11.6.1 Takeda Pharmaceutical Company Ltd. (Japan) Company Details

11.6.2 Takeda Pharmaceutical Company Ltd. (Japan) Business Overview

11.6.3 Takeda Pharmaceutical Company Ltd. (Japan) Insomnia Pharmacological Treatment Introduction

11.6.4 Takeda Pharmaceutical Company Ltd. (Japan) Revenue in Insomnia Pharmacological Treatment Business (2020-2025)

11.6.5 Takeda Pharmaceutical Company Ltd. (Japan) Recent Development

11.7 Pernix Therapeutics (US)

11.7.1 Pernix Therapeutics (US) Company Details

11.7.2 Pernix Therapeutics (US) Business Overview

11.7.3 Pernix Therapeutics (US) Insomnia Pharmacological Treatment Introduction

11.7.4 Pernix Therapeutics (US) Revenue in Insomnia Pharmacological Treatment Business (2020-2025)

11.7.5 Pernix Therapeutics (US) Recent Development

11.8 Purdue Pharma L.P (US)

11.8.1 Purdue Pharma L.P (US) Company Details

11.8.2 Purdue Pharma L.P (US) Business Overview

11.8.3 Purdue Pharma L.P (US) Insomnia Pharmacological Treatment Introduction

11.8.4 Purdue Pharma L.P (US) Revenue in Insomnia Pharmacological Treatment Business (2020-2025)

11.8.5 Purdue Pharma L.P (US) Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Eisai, Co. Ltd. (Japan)

Merck & Co., Inc. (US)

Meda Consumer Healthcare Inc(US)

Pfizer Inc. (US)

Sanofi (France)

Takeda Pharmaceutical Company Ltd. (Japan)

Pernix Therapeutics(US)

Purdue Pharma L.P. (US)

List of Tables

Table 1. Global Insomnia Pharmacological Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Prescription Sleep Aids

Table 3. Key Players of Over-the-Counter Sleep Aids

Table 4. Global Insomnia Pharmacological Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Insomnia Pharmacological Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Insomnia Pharmacological Treatment Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Insomnia Pharmacological Treatment Market Share by Region (2020-2025)

Table 8. Global Insomnia Pharmacological Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Insomnia Pharmacological Treatment Market Share by Region (2026-2031)

Table 10. Insomnia Pharmacological Treatment Market Trends

Table 11. Insomnia Pharmacological Treatment Market Drivers

Table 12. Insomnia Pharmacological Treatment Market Challenges

Table 13. Insomnia Pharmacological Treatment Market Restraints

Table 14. Global Insomnia Pharmacological Treatment Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Insomnia Pharmacological Treatment Market Share by Players (2020-2025)

Table 16. Global Top Insomnia Pharmacological Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Insomnia Pharmacological Treatment as of 2024)

Table 17. Ranking of Global Top Insomnia Pharmacological Treatment Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Insomnia Pharmacological Treatment Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Insomnia Pharmacological Treatment, Headquarters and Area Served

Table 20. Global Key Players of Insomnia Pharmacological Treatment, Product and Application

Table 21. Global Key Players of Insomnia Pharmacological Treatment, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Insomnia Pharmacological Treatment Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Insomnia Pharmacological Treatment Revenue Market Share by Type (2020-2025)

Table 25. Global Insomnia Pharmacological Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Insomnia Pharmacological Treatment Revenue Market Share by Type (2026-2031)

Table 27. Global Insomnia Pharmacological Treatment Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Insomnia Pharmacological Treatment Revenue Market Share by Application (2020-2025)

Table 29. Global Insomnia Pharmacological Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Insomnia Pharmacological Treatment Revenue Market Share by Application (2026-2031)

Table 31. North America Insomnia Pharmacological Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Insomnia Pharmacological Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Insomnia Pharmacological Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Insomnia Pharmacological Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Insomnia Pharmacological Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Insomnia Pharmacological Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Insomnia Pharmacological Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Insomnia Pharmacological Treatment Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Insomnia Pharmacological Treatment Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Insomnia Pharmacological Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Insomnia Pharmacological Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Insomnia Pharmacological Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Insomnia Pharmacological Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Insomnia Pharmacological Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Insomnia Pharmacological Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 46. Eisai, Co. Ltd. (Japan) Company Details

Table 47. Eisai, Co. Ltd. (Japan) Business Overview

Table 48. Eisai, Co. Ltd. (Japan) Insomnia Pharmacological Treatment Product

Table 49. Eisai, Co. Ltd. (Japan) Revenue in Insomnia Pharmacological Treatment Business (2020-2025) & (US$ Million)

Table 50. Eisai, Co. Ltd. (Japan) Recent Development

Table 51. Merck & Co., Inc (US) Company Details

Table 52. Merck & Co., Inc (US) Business Overview

Table 53. Merck & Co., Inc (US) Insomnia Pharmacological Treatment Product

Table 54. Merck & Co., Inc (US) Revenue in Insomnia Pharmacological Treatment Business (2020-2025) & (US$ Million)

Table 55. Merck & Co., Inc (US) Recent Development

Table 56. Meda Consumer Healthcare Inc (US) Company Details

Table 57. Meda Consumer Healthcare Inc (US) Business Overview

Table 58. Meda Consumer Healthcare Inc (US) Insomnia Pharmacological Treatment Product

Table 59. Meda Consumer Healthcare Inc (US) Revenue in Insomnia Pharmacological Treatment Business (2020-2025) & (US$ Million)

Table 60. Meda Consumer Healthcare Inc (US) Recent Development

Table 61. Pfizer, Inc (US) Company Details

Table 62. Pfizer, Inc (US) Business Overview

Table 63. Pfizer, Inc (US) Insomnia Pharmacological Treatment Product

Table 64. Pfizer, Inc (US) Revenue in Insomnia Pharmacological Treatment Business (2020-2025) & (US$ Million)

Table 65. Pfizer, Inc (US) Recent Development

Table 66. Sanofi (France) Company Details

Table 67. Sanofi (France) Business Overview

Table 68. Sanofi (France) Insomnia Pharmacological Treatment Product

Table 69. Sanofi (France) Revenue in Insomnia Pharmacological Treatment Business (2020-2025) & (US$ Million)

Table 70. Sanofi (France) Recent Development

Table 71. Takeda Pharmaceutical Company Ltd. (Japan) Company Details

Table 72. Takeda Pharmaceutical Company Ltd. (Japan) Business Overview

Table 73. Takeda Pharmaceutical Company Ltd. (Japan) Insomnia Pharmacological Treatment Product

Table 74. Takeda Pharmaceutical Company Ltd. (Japan) Revenue in Insomnia Pharmacological Treatment Business (2020-2025) & (US$ Million)

Table 75. Takeda Pharmaceutical Company Ltd. (Japan) Recent Development

Table 76. Pernix Therapeutics (US) Company Details

Table 77. Pernix Therapeutics (US) Business Overview

Table 78. Pernix Therapeutics (US) Insomnia Pharmacological Treatment Product

Table 79. Pernix Therapeutics (US) Revenue in Insomnia Pharmacological Treatment Business (2020-2025) & (US$ Million)

Table 80. Pernix Therapeutics (US) Recent Development

Table 81. Purdue Pharma L.P (US) Company Details

Table 82. Purdue Pharma L.P (US) Business Overview

Table 83. Purdue Pharma L.P (US) Insomnia Pharmacological Treatment Product

Table 84. Purdue Pharma L.P (US) Revenue in Insomnia Pharmacological Treatment Business (2020-2025) & (US$ Million)

Table 85. Purdue Pharma L.P (US) Recent Development

Table 86. Research Programs/Design for This Report

Table 87. Key Data Information from Secondary Sources

Table 88. Key Data Information from Primary Sources

Table 89. Authors List of This Report

List of Figures

Figure 1. Insomnia Pharmacological Treatment Picture

Figure 2. Global Insomnia Pharmacological Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Insomnia Pharmacological Treatment Market Share by Type: 2024 VS 2031

Figure 4. Prescription Sleep Aids Features

Figure 5. Over-the-Counter Sleep Aids Features

Figure 6. Global Insomnia Pharmacological Treatment Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Insomnia Pharmacological Treatment Market Share by Application: 2024 VS 2031

Figure 8. Homecare Case Studies

Figure 9. Clinic Case Studies

Figure 10. Hospital Case Studies

Figure 11. Insomnia Pharmacological Treatment Report Years Considered

Figure 12. Global Insomnia Pharmacological Treatment Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global Insomnia Pharmacological Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Insomnia Pharmacological Treatment Market Share by Region: 2024 VS 2031

Figure 15. Global Insomnia Pharmacological Treatment Market Share by Players in 2024

Figure 16. Global Top Insomnia Pharmacological Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Insomnia Pharmacological Treatment as of 2024)

Figure 17. The Top 10 and 5 Players Market Share by Insomnia Pharmacological Treatment Revenue in 2024

Figure 18. North America Insomnia Pharmacological Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 19. North America Insomnia Pharmacological Treatment Market Share by Country (2020-2031)

Figure 20. United States Insomnia Pharmacological Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Canada Insomnia Pharmacological Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Insomnia Pharmacological Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Insomnia Pharmacological Treatment Market Share by Country (2020-2031)

Figure 24. Germany Insomnia Pharmacological Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. France Insomnia Pharmacological Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. U.K. Insomnia Pharmacological Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Italy Insomnia Pharmacological Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Russia Insomnia Pharmacological Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Nordic Countries Insomnia Pharmacological Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Insomnia Pharmacological Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Insomnia Pharmacological Treatment Market Share by Region (2020-2031)

Figure 32. China Insomnia Pharmacological Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Japan Insomnia Pharmacological Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. South Korea Insomnia Pharmacological Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Southeast Asia Insomnia Pharmacological Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. India Insomnia Pharmacological Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Australia Insomnia Pharmacological Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Insomnia Pharmacological Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Insomnia Pharmacological Treatment Market Share by Country (2020-2031)

Figure 40. Mexico Insomnia Pharmacological Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Brazil Insomnia Pharmacological Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Insomnia Pharmacological Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Insomnia Pharmacological Treatment Market Share by Country (2020-2031)

Figure 44. Turkey Insomnia Pharmacological Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Saudi Arabia Insomnia Pharmacological Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. UAE Insomnia Pharmacological Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Eisai, Co. Ltd. (Japan) Revenue Growth Rate in Insomnia Pharmacological Treatment Business (2020-2025)

Figure 48. Merck & Co., Inc (US) Revenue Growth Rate in Insomnia Pharmacological Treatment Business (2020-2025)

Figure 49. Meda Consumer Healthcare Inc (US) Revenue Growth Rate in Insomnia Pharmacological Treatment Business (2020-2025)

Figure 50. Pfizer, Inc (US) Revenue Growth Rate in Insomnia Pharmacological Treatment Business (2020-2025)

Figure 51. Sanofi (France) Revenue Growth Rate in Insomnia Pharmacological Treatment Business (2020-2025)

Figure 52. Takeda Pharmaceutical Company Ltd. (Japan) Revenue Growth Rate in Insomnia Pharmacological Treatment Business (2020-2025)

Figure 53. Pernix Therapeutics (US) Revenue Growth Rate in Insomnia Pharmacological Treatment Business (2020-2025)

Figure 54. Purdue Pharma L.P (US) Revenue Growth Rate in Insomnia Pharmacological Treatment Business (2020-2025)

Figure 55. Bottom-up and Top-down Approaches for This Report

Figure 56. Data Triangulation

Figure 57. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Insomnia Therapeutics Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Sleeping Pills Market Research Report 2025

Global Sleeping Pills Prescription Drugs Market Research Report 2025

Global Antidepressant Medication Market Research Report 2025

Global Still s Disease Treatment Market Research Report 2025

Global Sleep Apnea Therapy System Market Research Report 2025

Global Anti Infectives Market Research Report 2025

Global Treatment Planning Software Market Research Report 2025

Global Sleep Apnoea Treatment Devices Market Insights Forecast to 2030

Global Combination Therapy Drug Market Research Report 2025

Global Drug Safety and Pharmacovigilance Service Market Research Report 2025

Global Medicines for Alzheimer Disease Treatment Market Research Report 2025

Global Drugs of Abuse Testing Market Research Report 2024

Antidepressants Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Pharmaceutical Compliance Service Market Research Report 2025

Global Inhaled Anti Infectives Market Research Report 2025

Global Weekly Pill Organizer Market Research Report 2025

Global Diagnostic Guidewire Market Research Report 2024

Global Pharmaceutical Asset Management Market Research Report 2025

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions